Your browser doesn't support javascript.
loading
HuR is required for IL-17-induced Act1-mediated CXCL1 and CXCL5 mRNA stabilization.
Herjan, Tomasz; Yao, Peng; Qian, Wen; Li, Xiao; Liu, Caini; Bulek, Katarzyna; Sun, Dongxu; Yang, Wen-Pin; Zhu, Jun; He, Aiqing; Carman, Julie A; Erzurum, Serpil C; Lipshitz, Howard D; Fox, Paul L; Hamilton, Thomas A; Li, Xiaoxia.
Afiliación
  • Herjan T; Department of Immunology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USA.
J Immunol ; 191(2): 640-9, 2013 Jul 15.
Article en En | MEDLINE | ID: mdl-23772036
ABSTRACT
IL-17, a major inflammatory cytokine plays a critical role in the pathogenesis of many autoimmune inflammatory diseases. In this study, we report a new function of RNA-binding protein HuR in IL-17-induced Act1-mediated chemokine mRNA stabilization. HuR deficiency markedly reduced IL-17-induced chemokine expression due to increased mRNA decay. Act1-mediated HuR polyubiquitination was required for the binding of HuR to CXCL1 mRNA, leading to mRNA stabilization. Although IL-17 induced the coshift of Act1 and HuR to the polysomal fractions in a sucrose gradient, HuR deficiency reduced the ratio of translation-active/translation-inactive IL-17-induced chemokine mRNAs. Furthermore, HuR deletion in distal lung epithelium attenuated IL-17-induced neutrophilia. In summary, HuR functions to couple receptor-proximal signaling to posttranscriptional machinery, contributing to IL-17-induced inflammation.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Interleucina-17 / Estabilidad del ARN / Proteínas Adaptadoras Transductoras de Señales / Proteínas ELAV / Quimiocina CXCL1 / Quimiocina CXCL5 Límite: Animals / Humans Idioma: En Revista: J Immunol Año: 2013 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Interleucina-17 / Estabilidad del ARN / Proteínas Adaptadoras Transductoras de Señales / Proteínas ELAV / Quimiocina CXCL1 / Quimiocina CXCL5 Límite: Animals / Humans Idioma: En Revista: J Immunol Año: 2013 Tipo del documento: Article País de afiliación: Estados Unidos